Sort
82,697 grants matching “vaccine development”
Production Development
$1,661,879Niranjan Y Sardesai · Wistar Institute · U19 · FY2019 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$1,661,610Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MEN
$1,660,822University Of California Los Angeles · U01 · FY2001 · AI
Lyme Disease: B cell epitope discovery and mechanisms of antibody protection
$1,660,786Nicholas J Mantis · Nysdoh/Health Research, Inc. · N01 · FY2019 · AI
The humoral response to Zika virus infection and vaccination
$1,660,387Theodore Pierson · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS
$1,660,208Therion Biologics Corporation · P01 · FY2000 · AI
Evaluation of HIV-1 Vaccine Candidates in Macaca mulatta
$1,659,714Lindsay M. Wohlers · Novartis Vaccines And Diagnostics, Inc. · P01 · FY2010 · AI
A-Z Clinical Trials Unit
$1,659,641Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2024 · AI
Preventive Vaccines for HIV
$1,659,426Genoveffa Franchini · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Development of a Safer Smallpox Vaccine
$1,658,791Arizona State University-Tempe Campus · U01 · FY2005 · AI
SARS-CoV-2 Virology Core
$1,658,179Reed Johnson · National Institute Of Allergy And Infectious Diseases · ZIC · FY2023 · AI
Translational Research to Prevent and Control Global Infectious Diseases (Translational Global Infectious Diseases Research Center, TGIR).
$1,658,162Beth Diane Kirkpatrick · University Of Vermont & St Agric College · P20 · FY2021 · GM
Genomic profiling of influenza infections to identify biomarkers of disease severity
$1,658,114Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Host-pathogen interactions in filarial worm infections
$1,658,114Elodie Ghedin · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
NONHUMAN PRIMATE PURCHASE AND HOLDING
$1,657,672Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Immune correlates of protection
$1,657,456Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
HIV/SIV Replication In Vivo
$1,657,456Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Core--Project Coordination and Product Development
$1,657,367Mark B. Feinberg · Emory University · U19 · FY2007 · AI
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,656,954Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Virus biology scientific research support component
$1,656,892Beatrice H Hahn · Duke University · UM1 · FY2018 · AI
Development of Broadly Immunogenic and Universal Influenza Virus Vaccines
$1,656,766Audray Harris · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Simian Vaccine Evaluation Unit: Operation of a Nonhuman Primate Breeding Colony
$1,656,214Francois Villinger · University Of Louisiana At Lafayette · N01 · FY2021 · AI
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,655,651Michael B Oldstone · Scripps Research Institute, The · U01 · FY2010 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$1,655,505Pamela J Bjorkman · California Institute Of Technology · P01 · FY2025 · AI
Natural History of HPV Infection in Men: The HIM Study
$1,655,450H. Lee Moffitt Cancer Ctr &Res Inst · R01 · FY2005 · CA